John M. Simpson

Prop 71 Stem Cell Ownership Rules Must Guarantee Reasonable Prices For Drugs and Treatments;

For All Californians, Consumer Advocate Testifies

Superior Court Upholds Prop 71 And Rules Stem Cell Institute Is A State Agency;

Consumer Advocates Say Now It Must Act Like One

Stem Cell Institute Leaders Must Sever Ties to Gala San Francisco Fundraiser;

Donors and Donations Must Be Identified Publicly, Say Consumer Advocates

Prop 71 Stem Cell Conflict of Interest Rules For Advisory Groups Rely On Secrecy; Flout Public’s Right To Know, Consumer Advocates Warn

Stem Cell Gala Fundraiser In San Francisco Puts Prop 71. Institute Up For Sale

Stem-cell grants ought to hinge on public benefits

The San Jose Mercury News Companies like Genentech act like committed socialists when it comes to taxpayers and the government bearing the…

Stem-cell grants ought to hinge on public benefits

The San Jose Mercury News Companies like Genentech act like committed socialists when it comes to taxpayers and the government bearing the…

Consumer Advocates Call On Proposition 71 Stem Cell Committee To Keep Public Benefit Promises and Protect Taxpayers’ $6 Billion Investment

Consumer Advocates Warn Against Secret Deals in Stem Cell Financing Plan

Consumer Advocates Challenge Genentech Exec’s Claim That Biotech Won’t Take Stem Cell Money With Public Benefit Requirements

Consumer Advocates Say Wisconsin Research Group’s Stem Cell Prop. 71 Claims Are Outrageous Raid on California’s Treasury

Taxpayers must benefit from stem-cell research

Certainly drug firms are entitled to fair profits; they just aren't entitled to charge exorbitant rates for their products when taxpayers directly…

Consumer Advocates Say “Affordability Guarantees” Would Deflect Prop 71 Stem Cell Legal Challenge

Consumer Advocates Insist Prop 71 Rules Ensure Stem Cell Therapies Are Priced Fairly for All Californians

Letter Says Attorney General Should Have Right to Intervene

FTCR letter to Stem Cell Committee Chairman Robert Klein

Consumer Advocates Insist on ‘Public Benefit’ Guidelines for $6 Billion in California Stem Cell Research

Draft Rules Lack Enforcement; Need Provision to Block Unfair Pricing The proposed intellectual property (IP) rules incorporate some recommendations from the Foundation…

Stem Cell Ethics Committee Agrees with Consumer Advocates & Closes “Donor” Loophole

Stem Cell Panel Follows Some Key “Public Benefit” Proposals for Prop 71 Research

FTCR Calls for Affordability & Enforcement